OBJECTIVES: To investigate predictors of occult nipple-areolar complex (NAC) involvement in patients with carcinoma in situ (CIS) and to validate an online probability calculator (CancerMath; www.lifemath.net/cancer/breastcancer/nipplecalc/index.php). METHODS: Mastectomized patients with CIS (n = 104) were retrospectively selected. Clinicopathology and preoperative mammography, ultrasound, and magnetic resonance imaging (MRI) findings were analyzed. RESULTS: Histopathological NAC-positivity was confirmed in 20 (19.2%) patients. Short nipple-tumor distance and suspicious extension to the nipple by mammography were significant but ultrasound was not significant to predict NAC involvement. NAC-positive cases had MRI findings of shorter nippl...
After primary chemotherapy, large operable T2-T3 breast cancers might be suitable for nipple\u2013ar...
INTRODUCTION: The extent of calcified ductal carcinoma in situ (DCIS) detected by screening mammogra...
OBJECTIVES: Ductal carcinoma in situ (DCIS) is a risk factor for incomplete resection of breast canc...
To identify clinically occult nipple–areola complex (NAC) involvement using preoperative magnetic re...
Background Although nonmass enhancement (NME) extension to the nipple at preoperative MRI frequently...
BACKGROUND: As neoadjuvant chemotherapy (NAC) for breast cancer has become more widely used, so has ...
BACKGROUND: The selections of nipple-sparing mastectomy (NSM) are principally depending on oncologic...
Background As neoadjuvant chemotherapy (NAC) for breast cancer has become more widely used, so has n...
Background. Breast-conserving therapy (BCT) is an accepted therapeutic option for most breast cancer...
Abstract Introduction Nipple-sparing mastectomy (NSM) has gained much attention by enhancing the aes...
OBJECTIVE:We aimed to evaluate the predictive value of delayed 18F-FDG PET/CT for identifying malign...
We previously demonstrated that abnormal nipple aspirate fluid (NAF) cytology predicted residual bre...
OBJECTIVES: To identify preoperative features that could be used to predict invasive breast cancer i...
Purpose: The eligibility for nipple-sparing mastectomy (NSM) regarding subareolar non-mass enhanceme...
Objective: To evaluate the oncologic safety of nipple-sparing mastectomy (NSM) for breast cancer pat...
After primary chemotherapy, large operable T2-T3 breast cancers might be suitable for nipple\u2013ar...
INTRODUCTION: The extent of calcified ductal carcinoma in situ (DCIS) detected by screening mammogra...
OBJECTIVES: Ductal carcinoma in situ (DCIS) is a risk factor for incomplete resection of breast canc...
To identify clinically occult nipple–areola complex (NAC) involvement using preoperative magnetic re...
Background Although nonmass enhancement (NME) extension to the nipple at preoperative MRI frequently...
BACKGROUND: As neoadjuvant chemotherapy (NAC) for breast cancer has become more widely used, so has ...
BACKGROUND: The selections of nipple-sparing mastectomy (NSM) are principally depending on oncologic...
Background As neoadjuvant chemotherapy (NAC) for breast cancer has become more widely used, so has n...
Background. Breast-conserving therapy (BCT) is an accepted therapeutic option for most breast cancer...
Abstract Introduction Nipple-sparing mastectomy (NSM) has gained much attention by enhancing the aes...
OBJECTIVE:We aimed to evaluate the predictive value of delayed 18F-FDG PET/CT for identifying malign...
We previously demonstrated that abnormal nipple aspirate fluid (NAF) cytology predicted residual bre...
OBJECTIVES: To identify preoperative features that could be used to predict invasive breast cancer i...
Purpose: The eligibility for nipple-sparing mastectomy (NSM) regarding subareolar non-mass enhanceme...
Objective: To evaluate the oncologic safety of nipple-sparing mastectomy (NSM) for breast cancer pat...
After primary chemotherapy, large operable T2-T3 breast cancers might be suitable for nipple\u2013ar...
INTRODUCTION: The extent of calcified ductal carcinoma in situ (DCIS) detected by screening mammogra...
OBJECTIVES: Ductal carcinoma in situ (DCIS) is a risk factor for incomplete resection of breast canc...